Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Considers Quality Designations For Generics In State Stores

This article was originally published in PharmAsia News

Executive Summary

Indian regulators and the pharmaceutical industry are holding discussions about a government proposal to require a quality designation for generic drugs. The discussions are being held relative to government plans to open a network of generics-only pharmacies around the country. As part of that move, regulators want to ensure the network sells only quality generics, but there is no specific system currently in place for monitoring the quality of generics in India. The idea is that a quality mark on a drug would help buyers distinguish between an approved generic and a substandard alternative. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066860

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel